Allogeneic Transplant in HIV Patients (BMT CTN 0903)

NCT01410344 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
HIV

Interventions

DRUG: Fludarabine and Busulfan
DRUG: Fludarabine and Melphalan
DRUG: Busulfan and Fludarabine
DRUG: Cyclophosphamide and Total Body Irradiation

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]